Ophthalmic manifestations suggesting Kearns--Sayre Syndrome among young adults with cardiac conduction defects (RCD code: III-1A.5a)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2016, Vol 3, Issue 1
Abstract
Kearns-Sayre Syndrome is a multisystemic mitochondrial cytopathy characterized by specific ophthalmic signs, cardiac conduction disturbances with endocrine, musculoskeletal and central nervous system involvement. As a highly heterogeneous condition, establishing an accurate diagnosis of this disorder can often be seriously delayed. It usually occurs before the age of 20 with ocular symptoms at first. Cardiac manifestations include progressive degeneration of the conduction tissue, leading to different types of conduction disturbances, which in many cases are responsible for significant decrease of life expectancy. There is currently no causative therapy available for Kearns-Sayre Syndrome patients. Several interventions including ophthalmic or neurological may be necessary in order to improve the quality of life, however improving prognosis in this group of patients impose prompt recognitions of those, who require early pacemaker implantation. Therefore, the aim of this article is to review the current knowledge about Kearns-Sayre Syndrome in light of the most typical ophthalmic findings, which can handily be detected by cardiologists and applied to accelerate accurate diagnosis and elaborate the most appropriate therapeutic strategies. JRCD 2016; 3 (1): 5–8
Authors and Affiliations
Magdalena Karwat - Szwabowicz, Jagoda Miszczyk
Keywords
Related Articles
- EP ID EP244132
- DOI 10.20418/jrcd.vol3no1.257
- Views 119
- Downloads 0
Pulmonary hypertension inadequate to the clinical condition or hypoxemia disproportionate to the PH severity? (RCD code: II-1B.2)
We present four cases of patients with a history of a pulmonary hypertension (PH), who had a component of lung disease disproportionate to the PH severity. Detailed evaluation revealed pulmonary arterial hypertension (PA...
Severe course of dilated cardiomyopathy associated with Duchenne muscular dystrophy (RCD code: III‑1A.3a)
Inherited neuromuscular disorders, such as dystrophin-related disorders are frequently associated with cardiac involvement, mainly with cardiomyopathies. Dystrophin-related disorders are caused by the mutation in the dys...
Effect of first‑month specific therapy determines long‑term clinical outcome in patients with pulmonary arterial hypertension
Efficacy of pulmonary arterial hypertension (PAH)-specific therapy may differ among the patients depending on the PAH aetiology. Aim: To compare the real‐life efficacy of PAH‐specific therapy between non‐congenital hear...
Report from the 12th Meeting of the Myocardial and Pericardial Diseases Working Group of the European Society of Cardiology, 2015 in Florence, Italy
Nowadays, with a constant accumulation of data and knowledge, specialized and dedicated to particular problems meetings are thriving. The Working Group (WG) of the Myocardial and Peri‑ cardial Diseases of the European So...
Facilitating recognition and grouping the expertise in the main fields of rare cardiovascular diseases
Dear Friends and Colleagues, Dear Readers,We are pleased to deliver at your hands the second issue of your quarterly Journal of Rare Cardiovascular Diseases. The feedback we have received, after launching the Journal in...